Iron Deficiency in Depressive Disorders: A Review of Mechanisms, Clinical Relevance, and Treatment Perspectives
DOI:
https://doi.org/10.12775/QS.2025.43.62357Keywords
iron deficiency anemia, iron metabolism, depression, depressive disorder, neurotransmitters, ferritin, anemia and mental health, iron supplementation and depression, anemia and mood disordersAbstract
Purpose of the research:
Iron deficiency (ID) is one of the most common nutritional deficiencies globally and may play a role in the development of depressive symptoms, even in the absence of anemia. This review explores the physiological links between iron status and brain function, examines current evidence on the association between iron deficiency and depression, and evaluates the impact of iron supplementation as a potential adjunctive treatment in depressive disorders.
Materials and methods:
A narrative review was conducted using articles identified from PubMed and Google Scholar. Studies included observational data, clinical trials, and systematic reviews. The analysis focused on populations with iron deficiency (with or without anemia) and assessed the effects of iron status and supplementation on mood and psychiatric symptoms.
Results:
Iron plays a crucial role in monoamine neurotransmitter synthesis, energy metabolism, and brain development. Several studies suggest that ID may contribute to depressive symptoms, including fatigue, apathy, and low mood. Supplementation with iron, both oral and intravenous, has shown potential in improving mood, reducing fatigue, and enhancing response to antidepressant therapy, particularly in populations with iron deficiency without anemia.
Conclusions:
Iron deficiency may be an underrecognized factor in the development and persistence of depression. Routine assessment of iron status and appropriate supplementation could serve as a valuable adjunct in the management of depressive disorders. Further research is needed to establish standardized diagnostic criteria and treatment protocols.
References
[1] S. McWilliams, I. Singh, W. Leung, S. Stockler, and O. S. Ipsiroglu, “Iron deficiency and common neurodevelopmental disorders—A scoping review,” PLoS ONE, vol. 17, no. 9, p. e0273819, Sep. 2022, doi: 10.1371/journal.pone.0273819.
[2] H. Spence, C. J. McNeil, and G. D. Waiter, “The impact of brain iron accumulation on cognition: A systematic review,” PLoS ONE, vol. 15, no. 10, p. e0240697, Oct. 2020, doi: 10.1371/journal.pone.0240697.
[3] M. Kulaszyńska, S. Kwiatkowski, and K. Skonieczna-Żydecka, “The Iron Metabolism with a Specific Focus on the Functioning of the Nervous System,” Biomedicines, vol. 12, no. 3, p. 595, Mar. 2024, doi: 10.3390/biomedicines12030595.
[4] J. H. Duyn and J. Schenck, “CONTRIBUTIONS TO MAGNETIC SUSCEPTIBILITY OF BRAIN TISSUE,” NMR Biomed., vol. 30, no. 4, p. 10.1002/nbm.3546, Apr. 2017, doi: 10.1002/nbm.3546.
[5] A. R. Bogdan, M. Miyazawa, K. Hashimoto, and Y. Tsuji, “Regulators of Iron Homeostasis: New Players in Metabolism, Cell Death, and Disease,” Trends Biochem. Sci., vol. 41, no. 3, pp. 274–286, Mar. 2016, doi: 10.1016/j.tibs.2015.11.012.
[6] R. Coffey and T. Ganz, “Iron homeostasis: An anthropocentric perspective,” J. Biol. Chem., vol. 292, no. 31, pp. 12727–12734, Aug. 2017, doi: 10.1074/jbc.R117.781823.
[7] R. J. Ward, F. A. Zucca, J. H. Duyn, R. R. Crichton, and L. Zecca, “The role of iron in brain ageing and neurodegenerative disorders,” Lancet Neurol., vol. 13, no. 10, pp. 1045–1060, Oct. 2014, doi: 10.1016/S1474-4422(14)70117-6.
[8] R. C. McCarthy and D. J. Kosman, “Mechanisms and regulation of iron trafficking across the capillary endothelial cells of the blood-brain barrier,” Front. Mol. Neurosci., vol. 8, p. 31, Jul. 2015, doi: 10.3389/fnmol.2015.00031.
[9] D. Vela, “Hepcidin, an emerging and important player in brain iron homeostasis,” J. Transl. Med., vol. 16, no. 1, p. 25, Feb. 2018, doi: 10.1186/s12967-018-1399-5.
[10] T. Grubić Kezele and B. Ćurko-Cofek, “Age-Related Changes and Sex-Related Differences in Brain Iron Metabolism,” Nutrients, vol. 12, no. 9, p. 2601, Aug. 2020, doi: 10.3390/nu12092601.
[11] K. Jomova et al., “Essential metals in health and disease,” Chem. Biol. Interact., vol. 367, p. 110173, Nov. 2022, doi: 10.1016/j.cbi.2022.110173.
[12] G. Gao, L. You, J. Zhang, Y.-Z. Chang, and P. Yu, “Brain Iron Metabolism, Redox Balance and Neurological Diseases,” Antioxidants, vol. 12, no. 6, p. 1289, Jun. 2023, doi: 10.3390/antiox12061289.
[13] A. M. Wiegersma, C. Dalman, B. K. Lee, H. Karlsson, and R. M. Gardner, “Association of Prenatal Maternal Anemia With Neurodevelopmental Disorders,” JAMA Psychiatry, vol. 76, no. 12, pp. 1294–1304, Dec. 2019, doi: 10.1001/jamapsychiatry.2019.2309.
[14] M. Azami et al., “The association between anemia and postpartum depression: A systematic review and meta-analysis,” Casp. J. Intern. Med., vol. 10, no. 2, pp. 115–124, 2019, doi: 10.22088/cjim.10.2.115.
[15] Z. Li, W. Wang, X. Xin, X. Song, and D. Zhang, “Association of total zinc, iron, copper and selenium intakes with depression in the US adults,” J. Affect. Disord., vol. 228, pp. 68–74, Mar. 2018, doi: 10.1016/j.jad.2017.12.004.
[16] Q. Wu, Q. Ren, J. Meng, W.-J. Gao, and Y.-Z. Chang, “Brain Iron Homeostasis and Mental Disorders,” Antioxid. Basel Switz., vol. 12, no. 11, p. 1997, Nov. 2023, doi: 10.3390/antiox12111997.
[17] S. Levi, M. Ripamonti, A. S. Moro, and A. Cozzi, “Iron imbalance in neurodegeneration,” Mol. Psychiatry, vol. 29, no. 4, pp. 1139–1152, Apr. 2024, doi: 10.1038/s41380-023-02399-z.
[18] B. Elstrott, L. Khan, S. Olson, V. Raghunathan, T. DeLoughery, and J. J. Shatzel, “The role of iron repletion in adult iron deficiency anemia and other diseases,” Eur. J. Haematol., vol. 104, no. 3, pp. 153–161, Mar. 2020, doi: 10.1111/ejh.13345.
[19] H. E. Shah et al., “Iron Deficiency-Induced Changes in the Hippocampus, Corpus Striatum, and Monoamines Levels That Lead to Anxiety, Depression, Sleep Disorders, and Psychotic Disorders,” Cureus, vol. 13, no. 9, p. e18138, Sep. 2021, doi: 10.7759/cureus.18138.
[20] S. S. Michalak and W. Sterna, “Coexistence and clinical implications of anemia and depression in the elderly population,” Psychiatr. Pol., vol. 57, no. 3, pp. 517–528, Jun. 2023, doi: 10.12740/PP/147079.
[21] M. Shafi, F. Taufiq, H. Mehmood, S. Afsar, and A. Badar, “Relation between depressive disorder and iron deficiency anemia among adults reporting to a secondary healthcare facility: A hospital-based case control study,” Journal of the College of Physicians and Surgeons Pakistan, vol. 28, no. 6, pp. 456–459, Jun. 2018, doi: 10.29271/JCPSP.2018.06.456,.
[22] C. Berthou, J. P. Iliou, and D. Barba, “Iron, neuro-bioavailability and depression,” EJHaem, vol. 3, no. 1, pp. 263–275, Feb. 2022, doi: 10.1002/JHA2.321.
[23] C. Liu, R. Zhou, X. Peng, T. Zhu, W. Wei, and X. Hao, “Relationship between depressive symptoms and anemia among the middle-aged and elderly: a cohort study over 4-year period,” BMC Psychiatry, vol. 23, no. 1, pp. 1–12, Dec. 2023, doi: 10.1186/S12888-023-05047-6/TABLES/4.
[24] H. S. Lee, H. H. Chao, W. T. Huang, S. C. C. Chen, and H. Y. Yang, “Psychiatric disorders risk in patients with iron deficiency anemia and association with iron supplementation medications: A nationwide database analysis,” BMC Psychiatry, vol. 20, no. 1, pp. 1–9, May 2020, doi: 10.1186/S12888-020-02621-0/TABLES/5.
[25] M. A. Ciulei, N. Ahluwalia, B. J. J. McCormick, D. M. Teti, and L. E. Murray-Kolb, “Iron Deficiency is Related to Depressive Symptoms in United States Nonpregnant Women of Reproductive Age: A Cross-Sectional Analysis of NHANES 2005-2010,” Journal of Nutrition, vol. 153, no. 12, pp. 3521–3528, Dec. 2023, doi: 10.1016/j.tjnut.2023.09.023.
[26] S. Hidese, K. Saito, S. Asano, and H. Kunugi, “Association between iron-deficiency anemia and depression: A web-based Japanese investigation,” Psychiatry Clin Neurosci, vol. 72, no. 7, pp. 513–521, Jul. 2018, doi: 10.1111/PCN.12656;PAGE:STRING:ARTICLE/CHAPTER.
[27] A. Kassir, “Carence en fer : une perspective diagnostique et thérapeutique en psychiatrie,” Encephale, vol. 43, no. 1, pp. 85–89, Feb. 2017, doi: 10.1016/j.encep.2016.08.002.
[28] K. Mikami et al., “Iron Supplementation for Hypoferritinemia-Related Psychological Symptoms in Children and Adolescents,” Journal of Nippon Medical School, vol. 89, no. 2, pp. 203–211, 2022, doi: 10.1272/JNMS.JNMS.2022_89-216,.
[29] S. W. Levin and T. B. Gattari, “Iron deficiency in psychiatric patients,” Curr Psychiatr, vol. 22, no. 3, doi: 10.12788/cp.0337.
[30] B. L. Houston et al., “Efficacy of iron supplementation on fatigue and physical capacity in non-anaemic iron-deficient adults: A systematic review of randomised controlled trials,” BMJ Open, vol. 8, no. 4, Apr. 2018, doi: 10.1136/BMJOPEN-2017-019240,.
[31] M. Sheikh, S. Hantoushzadeh, M. Shariat, Z. Farahani, and O. Ebrahiminasab, “The efficacy of early iron supplementation on postpartum depression, a randomized double-blind placebo-controlled trial,” Eur J Nutr, vol. 56, no. 2, pp. 901–908, Mar. 2017, doi: 10.1007/S00394-015-1140-6/METRICS.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Michał Wycik, Gabriela Kondratiuk, Agnieszka Kruk, Marta Łupińska, Kamila Stępień, Julia Kucińska, Hubert Chmielewski, Artur Wądołowski, Joanna Przeniosło, Julia Komar
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 362
Number of citations: 0
